vs
Side-by-side financial comparison of AEMETIS, INC (AMTX) and NORTECH SYSTEMS INC (NSYS). Click either name above to swap in a different company.
AEMETIS, INC is the larger business by last-quarter revenue ($43.3M vs $30.3M, roughly 1.4× NORTECH SYSTEMS INC). On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -7.9%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $-10.8M). Over the past eight quarters, NORTECH SYSTEMS INC's revenue compounded faster (-5.9% CAGR vs -22.8%).
Aemetis, Inc. is a renewable fuels and sustainable biochemicals producer operating across North America and India. Its core products include low-carbon ethanol, renewable natural gas and biodiesel, serving transportation, industrial and agricultural sectors with decarbonization solutions for commercial clients.
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
AMTX vs NSYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.3M | $30.3M |
| Net Profit | — | $897.0K |
| Gross Margin | 17.8% | 16.7% |
| Operating Margin | -5.7% | 3.0% |
| Net Margin | — | 3.0% |
| Revenue YoY | -7.9% | 5.9% |
| Net Profit YoY | — | 160.7% |
| EPS (diluted) | $-0.03 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.3M | $30.3M | ||
| Q3 25 | $59.2M | $30.5M | ||
| Q2 25 | $52.2M | $30.7M | ||
| Q1 25 | $42.9M | $26.9M | ||
| Q4 24 | $47.0M | $28.6M | ||
| Q3 24 | $81.4M | $31.4M | ||
| Q2 24 | $66.6M | $33.9M | ||
| Q1 24 | $72.6M | $34.2M |
| Q4 25 | — | $897.0K | ||
| Q3 25 | $-23.7M | $-146.0K | ||
| Q2 25 | $-23.4M | $313.0K | ||
| Q1 25 | $-24.5M | $-1.3M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-17.9M | $-739.0K | ||
| Q2 24 | $-29.2M | $157.0K | ||
| Q1 24 | $-24.2M | $765.0K |
| Q4 25 | 17.8% | 16.7% | ||
| Q3 25 | -0.1% | 16.5% | ||
| Q2 25 | -6.4% | 15.8% | ||
| Q1 25 | -11.8% | 11.4% | ||
| Q4 24 | -4.3% | 9.9% | ||
| Q3 24 | 4.8% | 12.2% | ||
| Q2 24 | -2.7% | 13.6% | ||
| Q1 24 | -0.8% | 15.9% |
| Q4 25 | -5.7% | 3.0% | ||
| Q3 25 | -14.4% | 3.1% | ||
| Q2 25 | -20.4% | 2.4% | ||
| Q1 25 | -36.3% | -6.0% | ||
| Q4 24 | -28.7% | -4.3% | ||
| Q3 24 | -4.8% | -1.5% | ||
| Q2 24 | -20.4% | 1.0% | ||
| Q1 24 | -13.0% | 3.4% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | -40.1% | -0.5% | ||
| Q2 25 | -44.8% | 1.0% | ||
| Q1 25 | -57.2% | -4.9% | ||
| Q4 24 | — | -5.2% | ||
| Q3 24 | -22.0% | -2.4% | ||
| Q2 24 | -43.8% | 0.5% | ||
| Q1 24 | -33.4% | 2.2% |
| Q4 25 | $-0.03 | $0.32 | ||
| Q3 25 | $-0.37 | $-0.05 | ||
| Q2 25 | $-0.41 | $0.12 | ||
| Q1 25 | $-0.47 | $-0.48 | ||
| Q4 24 | $-0.29 | $-0.51 | ||
| Q3 24 | $-0.38 | $-0.27 | ||
| Q2 24 | $-0.66 | $0.05 | ||
| Q1 24 | $-0.58 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $1.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-306.8M | $34.5M |
| Total Assets | $259.8M | $71.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $1.7M | ||
| Q3 25 | $5.6M | $1.3M | ||
| Q2 25 | $1.6M | $652.0K | ||
| Q1 25 | $499.0K | $1.2M | ||
| Q4 24 | $898.0K | $916.0K | ||
| Q3 24 | $296.0K | $1.2M | ||
| Q2 24 | $234.0K | $1.5M | ||
| Q1 24 | $1.6M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $338.1M | — | ||
| Q3 24 | $322.2M | — | ||
| Q2 24 | $309.0M | — | ||
| Q1 24 | $307.2M | — |
| Q4 25 | $-306.8M | $34.5M | ||
| Q3 25 | $-304.9M | $33.4M | ||
| Q2 25 | $-289.3M | $33.4M | ||
| Q1 25 | $-280.7M | $32.8M | ||
| Q4 24 | $-263.9M | $34.0M | ||
| Q3 24 | $-258.9M | $35.7M | ||
| Q2 24 | $-249.0M | $36.1M | ||
| Q1 24 | $-232.1M | $36.0M |
| Q4 25 | $259.8M | $71.9M | ||
| Q3 25 | $241.1M | $74.8M | ||
| Q2 25 | $240.0M | $74.8M | ||
| Q1 25 | $242.5M | $73.5M | ||
| Q4 24 | $259.3M | $72.4M | ||
| Q3 24 | $259.3M | $77.0M | ||
| Q2 24 | $259.3M | $76.3M | ||
| Q1 24 | $259.3M | $75.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | $5.6M |
| Free Cash FlowOCF − Capex | $-10.8M | $5.5M |
| FCF MarginFCF / Revenue | -24.9% | 18.0% |
| Capex IntensityCapex / Revenue | 38.2% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 6.25× |
| TTM Free Cash FlowTrailing 4 quarters | $-22.7M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $5.6M | ||
| Q3 25 | $3.1M | $-92.0K | ||
| Q2 25 | $-5.7M | $157.0K | ||
| Q1 25 | $160.0K | $-2.9M | ||
| Q4 24 | $-12.6M | $793.0K | ||
| Q3 24 | $-5.0M | $-1.6M | ||
| Q2 24 | $-5.1M | $-4.3M | ||
| Q1 24 | $-10.3M | $2.8M |
| Q4 25 | $-10.8M | $5.5M | ||
| Q3 25 | $-1.0M | $-242.0K | ||
| Q2 25 | $-9.3M | $58.0K | ||
| Q1 25 | $-1.7M | $-3.2M | ||
| Q4 24 | $-19.4M | $503.0K | ||
| Q3 24 | $-9.5M | $-1.6M | ||
| Q2 24 | $-10.5M | $-4.6M | ||
| Q1 24 | $-13.9M | $2.1M |
| Q4 25 | -24.9% | 18.0% | ||
| Q3 25 | -1.7% | -0.8% | ||
| Q2 25 | -17.7% | 0.2% | ||
| Q1 25 | -3.9% | -11.9% | ||
| Q4 24 | -41.2% | 1.8% | ||
| Q3 24 | -11.6% | -5.2% | ||
| Q2 24 | -15.8% | -13.5% | ||
| Q1 24 | -19.1% | 6.1% |
| Q4 25 | 38.2% | 0.5% | ||
| Q3 25 | 6.9% | 0.5% | ||
| Q2 25 | 6.7% | 0.3% | ||
| Q1 25 | 4.3% | 1.0% | ||
| Q4 24 | 14.4% | 1.0% | ||
| Q3 24 | 5.5% | 0.1% | ||
| Q2 24 | 8.1% | 0.8% | ||
| Q1 24 | 4.9% | 2.2% |
| Q4 25 | — | 6.25× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -27.30× | ||
| Q1 24 | — | 3.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMTX
| Ethanol Sales | $28.8M | 66% |
| Wet Distillers Grains | $6.8M | 16% |
| California Dairy Renewable Natural Gas | $5.2M | 12% |
| Other | $1.8M | 4% |
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
